Browsing by Author Yuen, JCH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 49 to 68 of 75 < previous   next >
TitleAuthor(s)Issue DateViews
 
Prevalence and significance of hepatitis GB virus-C/hepatitis G virus viremia in a large cohort of patients with chronic hepatitis B infection, with chronic hepatitis C infection, and on renal replacement therapy in Hong Kong
Journal:Digestive Diseases and Sciences
Yuen, MFChan, TMTerence PokSiu, YIPYuen, JCHHo, SKNLai, CL
2002
118
 
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: A study of a large blood donor population
Journal:Gut
Yuen, MFLee, CKWong, DKHFung, JHung, IHsu, ABut, DYKCheung, TKChan, PYuen, JCHFung, FKCSeto, WKLin, CKLai, CL
2010
152
 
Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
Proceeding/Conference:Hepatology
Fung, JYYLai, CLTanaka, YMizokami, MYuen, JCHWong, DKHYuen, RMF
2007
81
 
Profound reduction of HBV covalently closed circular DNA with long-term nucleoside/tide analogue therapy
Proceeding/Conference:Hepatology
Lai, CLWong, DKHIp, PKopaniszen, MSeto, WKFung, JHuang, FYLee, BPCullaro, GWu, CHCheng, CYuen, JCHNgai, VYuen, MF
2014
90
 
Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications
Journal:Gut
Yuen, MFYuan, HJWong, DKHYuen, JCHWong, WMChan, AOOWong, BCYLai, KCLai, CL
2005
137
 
Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma
Journal:Journal of Hepatology
Wong, DKHYuen, MFPoon, RTPYuen, JCHFung, JLai, CL
2006
168
 
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B
Journal:Antiviral Therapy
Yuen, MFKim, JKim, CRNgai, VYuen, JCHMin, CKang, HMShin, BSYoo, SDLai, CL
2006
122
 
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable cccDNA
Proceeding/Conference:Hepatology
Lai, CLWong, DKHYuen, JCHWu, CHCheng, CTKNgai, WSKopaniszen, MSeto, WKWFung, JYYYuen, RMF
2017
60
 
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Journal:Journal of Hepatology
Lai, CLWong, DKHIp, PCPKopaniszen, MSeto, WKWFung, JYYHuang, FYLee, BCullaro, GChong, CKWu, CHCheng, CTKYuen, JCHNgai, WSYuen, RMF
2017
83
 
Reduction of hepatitis B core related antigen by long term nucleoside nucleotide analogue therapy and its correlation with intrahepatic HBV DNA reduction
Proceeding/Conference:Hepatology International
Wong, DKopaniszen, MSeto, WKFung, JHung, IYoung, JLPYuen, JCHNgai, VWSYuen, MFLai, CL
2015
194
 
Risk factors and post-resection independent predictive score for the recurrence of hepatitis B-related hepatocellular carcinoma
Proceeding/Conference:Hong Kong Medical Journal
Hung, IFNWong, DKHPoon, RTPFong, DYTChui, AHWSeto, WKFung, JYYChan, ACYYuen, JCHTiu, RChoi, OLai, CLYuen, MF
2015
42
 
Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma
Journal:PLoS ONE
Hung, FNIWong, DKHPoon, RTPFong, DYTChui, AHWSeto, WKWFung, JYYChan, ACYYuen, JCHTiu, TMRJCHOI, MYOLai, CLYuen, RMF
2016
79
 
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels
Journal:Gut
Yuen, MFTanaka, YShinkai, NPoon, RTBut, DYKFong, DYTFung, JWong, DKHYuen, JCHMizokami, MLai, CL
2008
117
 
Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesis
Proceeding/Conference:Journal of Hepatology
Yuen, RMFTanaka, YShinkai, NPoon, RTPFung, JYYWong, DKHYuen, JCHMizokami, MLai, CL
2007
167
 
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: A case control study
Journal:Carcinogenesis
Yuen, MFTanaka, YMizokami, MYuen, JCHWong, DKHYuan, HJSum, SMChan, AOOWong, BCYLai, CL
2004
162
 
Screening of occult HBV infection in blood donors in Hong Kong using nucleic acid testing
Proceeding/Conference:Journal of Hepatology
Wong, DKHLai, CLFung, JYYLee, CKLin, CKHung, IFNBut, DHsu, AChan, PCheung, TKFung, FKCYuen, JCHYoung, JLPNgai, VWSYuen, RMF
2008
173
 
Sequential therapy using lamivudine in entecavir-treated patients with undetectable HBV DNA–results at 48 weeks
Proceeding/Conference:Hepatology
Fung, JYYLai, CLYuen, JCHCheng, CTKWu, CHYuen, RMF
2009
36
 
Serologic and virologic kinetics after stopping nucleoside analogue therapy in hepatitis B surface antigen (HBSAG) seroclearance
Proceeding/Conference:Journal of Hepatology
Seto, WKWong, DKHFung, JYuen, JCHHung, IFNLai, CLYuen, RMF
2012
519
 
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
Journal:Hepatology International
Seto, WKWong, DKHFung, JHung, IFNYuen, JCHTong, TLai, CLYuen, MF
2013
79
 
Serum hepatitis B surface antigen (HBSAG) titers and HBV DNA levels in Hepatitis B E antigen (HBEAG)-negative chronic Hepatitis B: an interim analysis
Proceeding/Conference:Hepatology
Seto, WKLai, CLFung, JWong, DYuen, JCHYoung, JLPTong, TSMHung, IFNYuen, MF
2011
32
Showing results 49 to 68 of 75 < previous   next >